Treace Medical Concepts, Inc. (TMCI) vs X4 Pharmaceuticals, Inc. (XFOR)
A side-by-side comparison of Treace Medical Concepts, Inc. and X4 Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
TMCI
Treace Medical Concepts, Inc.
$4.00HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
XFOR
X4 Pharmaceuticals, Inc.
$2.77HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — TMCI vs XFOR
growth of $100 · dividends reinvested · last 5yTMCI -82.5% (-29.4%/yr)XFOR -98.9% (-59.7%/yr)TMCI compounded faster over this window
Log scale — wide-divergence pair
TMCI XFOR
TMCI vs XFOR: by the numbers
- •XFOR is the larger company ($261M vs $259M market cap).
- •Both run net losses; TMCI's is the smaller (-28.99% vs -568.80% net margin).
Metrics side by side
Valuation
| Metric | TMCI | XFOR |
|---|---|---|
| P/S ratio | 1.26 | 16.49 |
| P/B ratio | 3.83 | 1.68 |
Profitability
| Metric | TMCI | XFOR |
|---|---|---|
| Gross margin | 79.45% | 81.22% |
| Operating margin | -26.17% | -247.44% |
| Net margin | -28.99% | -568.80% |
| ROE | -87.86% | -57.98% |
| ROIC | -37.64% | -37.61% |
Growth (annualized)
| Metric | TMCI | XFOR |
|---|---|---|
| Revenue CAGR (5Y) | 21.44% | N/A |
| Total return CAGR (5Y) | -29.41% | -55.06% |
Frequently asked
- How have TMCI and XFOR total returns compared?
- Over the past 5 years, TMCI delivered -29.41% and XFOR delivered -55.06% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Treace Medical Concepts ROEX4 Pharmaceuticals ROETreace Medical Concepts operating marginX4 Pharmaceuticals operating marginTreace Medical Concepts revenue growthX4 Pharmaceuticals revenue growthTreace Medical Concepts free cash flowX4 Pharmaceuticals free cash flow
Treace Medical Concepts & X4 Pharmaceuticals appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.